జర్నల్ ఆఫ్ డయాబెటిస్ & మెటబాలిజం

Hospitalisation Due to Heart Failure with Gliptins and Universal Label Change (FDA)-Still Justified? A Meta-Analysis of 5 Cardiovascular Outcomes Trials

Samit Ghosal and Awadhesh Kumar Singh